Ganciclovir. An update of its therapeutic use in cytomegalovirus infection (Q40395491)

20 September 2017

1 reference

title

Ganciclovir. An update of its therapeutic use in cytomegalovirus infection (English)

1 reference

20 September 2017

0 references

1

A Markham

0 references

author name string

A Markham

series ordinal

1

1 reference

20 September 2017

D Faulds

series ordinal

2

1 reference

20 September 2017

publication date

1 September 1994

1 reference

20 September 2017

1 reference

20 September 2017

volume

48

1 reference

20 September 2017

issue

3

1 reference

20 September 2017

page(s)

455-484

1 reference

Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies

20 September 2017

cites work

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Combined short- and long-term therapy for the treatment of cytomegalovirus retinitis using ganciclovir (BW B759U)

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Management and prevention of cytomegalovirus infection after renal transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Human pharmacokinetics of the antiviral drug DHPG.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

[Ganciclovir therapy of congenital cytomegalovirus infections]

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Treatment of cytomegalovirus pneumonia with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine and high-dose corticosteroids

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Human cytomegalovirus in a SCID-hu mouse: thymic epithelial cells are prominent targets of viral replication

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir therapy of congenital cytomegalovirus disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir for the treatment of cytomegalovirus gastroenteritis in bone marrow transplant patients. A randomized, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Immune responses after ganciclovir and immunoglobulin therapy of infants

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Metabolic activation of the nucleoside analog 9-[( 2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human diploid fibroblasts infected with human cytomegalovirus

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Fatal congenital cytomegalovirus infection acquired by an intra-uterine transfusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Tolerability of combined ganciclovir and didanosine for the treatment of cytomegalovirus disease associated with AIDS.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir/foscarnet for cytomegalovirus meningoencephalitis in AIDS

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Human pharmacokinetics and tolerance of oral ganciclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Intravitreal therapy with ganciclovir for posterior pole cytomegalovirus retinitis in AIDS patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir pharmacokinetics during renal impairment

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Cytomegalovirus infection and disease after bone marrow transplantation: epidemiology, prevention, and treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Seizures associated with ganciclovir therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Combination ganciclovir and foscarnet in the treatment of clinically resistant cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Intracellular metabolism and enzymatic phosphorylation of 9-(1,3-dihydroxy-2-propoxymethyl)guanine and acyclovir in herpes simplex virus-infected and uninfected cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Long-term intravitreal ganciclovir therapy for cytomegalovirus retinopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir treatment of cytomegalovirus infections in iatrogenically immunocompromised patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir treatment of life- or sight-threatening cytomegalovirus infection: experience in 314 immunocompromised patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Successful management of symptomatic cytomegalovirus disease with ganciclovir after heart transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Psychiatric Disturbances Associated with Ganciclovir Therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Prophylactic use of ganciclovir for allogeneic bone marrow transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Linear single-dose pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. NIAID Collaborative Antiviral Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir treatment for cytomegalovirus infections in renal transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Interaction of 9-(1,3-dihydroxy-2-propoxymethyl)guanine with cytosol and mitochondrial deoxyguanosine kinases: possible role in anti-cytomegalovirus activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Prospective study of cytomegalovirus infection in liver transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Treatment of severe cytomegalovirus infection with ganciclovir and high-dose intravenous immunoglobulin in patients with allogeneic bone marrow transplants. A pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir antagonizes the anti-human immunodeficiency virus type 1 activity of zidovudine and didanosine in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Treatment of aggressive cytomegalovirus retinitis with ganciclovir in combination with foscarnet in a child infected with human immunodeficiency virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir therapy for symptomatic congenital cytomegalovirus infection in infants: a two-regimen experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Anti-herpesvirus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Treatment of cytomegalovirus retinitis with ganciclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

In vitro susceptibility of cytomegalovirus isolates from immunocompromised patients to acyclovir and ganciclovir.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Toxicity of combined ganciclovir and zidovudine for cytomegalovirus disease associated with AIDS. An AIDS Clinical Trials Group Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Survival of patients with AIDS and cytomegalovirus disease treated with ganciclovir or foscarnet.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Effect of combinations of difluoromethylornithine (DFMO) and 9[(1,3-dihydroxy-2-propoxy) methyl]guanine (DHPG) on human cytomegalovirus

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir prophylaxis for cytomegalovirus infections in pulmonary allograft recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Prevalence of Resistance in Patients Receiving Ganciclovir for Serious Cytomegalovirus Infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir transfer by human placenta and its effects on rat fetal cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

In vitro and in vivo activities of phosphate derivatives of 9-(1,3-dihydroxy-2-propoxymethyl)-guanine against cytomegaloviruses

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

9-(1,3-Dihydroxy-2-propoxymethyl)guanine (ganciclovir) in the treatment of cytomegalovirus gastrointestinal disease with the acquired immunodeficiency syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Failure of adjunctive cytomegalovirus intravenous immune globulin to improve efficacy of ganciclovir in patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis: a phase 1 study

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir treatment of serious cytomegalovirus infection in heart and heart-lung transplant recipients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Clinical patterns and treatment of cytomegalovirus infection after solid-organ transplantation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Didanosine. A review of its antiviral activity, pharmacokinetic properties and therapeutic potential in human immunodeficiency virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

CMV infections following allogeneic BMT: risk factors, early treatment and correlation with transplant related mortality

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

2'-Nor-cGMP: a seco-cyclic nucleotide with powerful anti-DNA-viral activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Foscarnet and Ganciclovir in the treatment of CMV retinitis in AIDS patients: a randomised comparison

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Intravitreal ganciclovir concentration after intravenous administration in AIDS patients with cytomegalovirus retinitis: implications for therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Liposomally-entrapped ganciclovir for the treatment of cytomegalovirus retinitis in AIDS patients. Eperimental toxicity and pharmacokinetics, and clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Antiviral activity of anti-cytomegalovirus agents (HPMPC, HPMPA) assessed by a flow cytometric method and DNA hybridization technique

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Pharmacokinetics of ganciclovir in heart transplant patients undergoing continuous venovenous hemodialysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir and hyperimmunoglobulin for treating cytomegalovirus infection in bone marrow transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

BW B759U for cytomegalovirus retinitis: intraocular drug penetration

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Safety of alternating ganciclovir and foscarnet maintenance therapy in human immunodeficiency virus (HIV)-related cytomegalovirus infections. An open-labeled pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Prophylaxis of cytomegalovirus infection with ganciclovir in allogeneic marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Combination therapy with ganciclovir and intravenous IgG for cytomegalovirus infections in pediatric liver transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients. A randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Xanthomonas maltophilia endophthalmitis after implantation of sustained-release ganciclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

New approaches to the diagnosis, prevention, and treatment of cytomegalovirus infection after transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Basic biology of the hematopoietic growth factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir with recombinant methionyl human granulocyte colony-stimulating factor for treatment of cytomegalovirus disease in AIDS patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir therapy of severe cytomegalovirus infections in solid-organ transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir in cytomegalovirus prophylaxis in high-risk pediatric renal transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Cytomegalovirus colitis in AIDS: presentation in 44 patients and a review of the literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Antiviral activity and mechanism of action of ganciclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Increased efficacy of ganciclovir and foscarnet inhibition of cytomegalovirus replication in vitro by encapsulation in liposomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Randomized trial of ganciclovir followed by high-dose oral acyclovir vs ganciclovir alone in the prevention of cytomegalovirus disease in pediatric liver transplant recipients: preliminary analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Treatment of CMV retinitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Use of ganciclovir to treat serious cytomegalovirus infections in patients with AIDS

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Survival of patients with the acquired immune deficiency syndrome after development of cytomegalovirus retinopathy. UCLA CMV Retinopathy Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Controlled trial of prophylactic versus therapeutic use of ganciclovir after liver transplantation in adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Efficacy of ganciclovir in combination with zidovudine against cytomegalovirus in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Treatment of herpesvirus infections in HIV-infected individuals

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Prospective study of the incidence, timing, significance, risk factors, and outcome of cytomegalovirus infection in liver transplant patients with double-drug immunosuppression and no prophylactic antiviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (1110U81) potently inhibits human cytomegalovirus replication and potentiates the antiviral effects of ganciclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Comparative activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against rat cytomegalovirus infection in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Patterns of cytomegalovirus retinitis in immunocompromised patients treated with 9-(2-hydroxy-1-(hydroxymethyl)ethoxymethyl) guanine (ganciclovir).

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Activity of different antiviral drug combinations against human cytomegalovirus replication in vitro.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Cytomegalovirus Infection in Patients with AIDS

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

A Randomized, Controlled Trial of Foscarnet in the Treatment of Cytomegalovirus Retinitis in Patients with AIDS

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Comparative activity of selected antiviral compounds against clinical isolates of human cytomegalovirus

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Retinal and gastrointestinal disease due to cytomegalovirus in patients with the acquired immune deficiency syndrome: prevalence, natural history, and response to ganciclovir therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Prophylactic use of ganciclovir in allogeneic bone marrow transplantation: absence of clinical cytomegalovirus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Foscarnet and ganciclovir in the treatment of cytomegalovirus retinitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir therapy for cytomegalovirus infections in recipients of bone marrow transplants and other immunosuppressed patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir treatment of cytomegalovirus infection in heart-lung and double-lung transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir for the treatment and suppression of serious infections caused by cytomegalovirus

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

CMV encephalitis during ganciclovir therapy of CMV retinitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Phosphorylation of the antiviral precursor 9-(1,3-dihydroxy-2-propoxymethyl)guanine monophosphate by guanylate kinase isozymes

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Treatment of renal transplant-associated cytomegalovirus infection with ganciclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Concurrent use of ganciclovir and foscarnet to treat cytomegalovirus infection in AIDS patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir therapy of symptomatic cytomegalovirus infection in renal transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Use of ganciclovir in the treatment of cytomegalovirus infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Cytomegalovirus retinopathy and the acquired immune deficiency syndrome: results of treatment with ganciclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir therapy for cytomegalovirus disease associated with renal transplants

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Randomized prospective trial of ganciclovir maintenance therapy for cytomegalovirus retinitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir effectively treats cytomegalovirus disease after solid-organ transplantation, even during rejection treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Treatment of cytomegalovirus retinitis with ganciclovir and foscarnet

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Simultaneous treatment of cytomegalovirus retinitis with ganciclovir and foscarnet

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Use of gancyclovir in AIDS patients with low CD4 counts and high IGG titers as preventive therapy against CMV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Treatment of cytomegalovirus retinitis with zidovudine and ganciclovir in patients with AIDS: outcome and toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Pharmacokinetics of ganciclovir in renal transplant children

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Pathophysiology and treatment of clinically resistant cytomegalovirus retinitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

A human cytomegalovirus mutant resistant to the nucleoside analog 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine (BW B759U) induces reduced levels of BW B759U triphosphate

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

DHPG at CMV viremia after allogeneic bone marrow transplantation. Result over a four year period (1986-1990)

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Inhibitory effects of potent inhibitors of human immunodeficiency virus and cytomegalovirus on the growth of human granulocyte-macrophage progenitor cells in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir treatment of cytomegalovirus colitis in AIDS: a randomized, double-blind, placebo-controlled multicenter study

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Effect of prophylactic ganciclovir on cytomegalovirus infection in renal transplant recipients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir treatment of gastrointestinal infections caused by cytomegalovirus in patients with AIDS

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir therapy of congenital cytomegalovirus pneumonia

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Comparative inhibitory effects of nucleoside analogues on different clinical isolates of human cytomegalovirus in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Point mutations in the DNA polymerase gene of human cytomegalovirus that result in resistance to antiviral agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Approaches to the treatment of cytomegalovirus retinitis: ganciclovir and foscarnet

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir prophylaxis decreases frequency and severity of cytomegalovirus disease in seropositive liver transplant recipients treated with OKT3 monoclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Intravitreal ganciclovir pharmacokinetics in rabbits and man

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Preemptive therapy with gancyclovir for early high-risk CMV infection allows effective treatment with antithymocyte globulin of steroid-resistant rejection after renal transplantation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Ganciclovir Treatment of Congenital Cytomegalovirus Infection: A report of two cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Cytomegalovirus resistant to foscarnet: clinicovirologic correlation in a patient with human immunodeficiency virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Therapeutic use of ganciclovir for invasive cytomegalovirus infection in cadaveric renal allograft recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

A modified procedure for intravitreal injections of ganciclovir in the treatment of cytomegalovirus retinitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

A Randomized Prospective Trial of Acyclovir and Immune Globulin Prophylaxis in Liver Transplant Recipients Receiving OKT3 Therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Combined ganciclovir and recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of cytomegalovirus retinitis in AIDS patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Cytomegalovirus pneumonia after bone marrow transplantation. Risk factors and response to therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

Safety considerations in the use of ganciclovir in immunocompromised patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7527763

12 December 2020

10.2165/00003495-199448030-00009

Identifiers

DOI

1 reference

Dimensions Publication ID

20 September 2017

1027516891

0 references

1 reference